BISvsIJH
ProShares UltraShort Nasdaq Biotechnology against iShares Core S&P Mid-Cap ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BIS | IJH | |
|---|---|---|
| Expense ratio | 0.95% | 0.050% |
| Assets | $1850.59T | $120.9B |
| Net flow, 1 month | — | +$1B |
| Net flow, 1 year | +$2K | +$11.1B |
| Return, YTD | -38.6% | +10.2% |
| Return, 1 year | -53.1% | +11.0% |
| Avg daily volume | 9K | 6.9M |
| Holdings | 7 | 415 |
| Listed | Apr 8, 2010 | May 21, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS